127 related articles for article (PubMed ID: 10485313)
1. Metabolic disturbances after a single dose of 30 mg pamidronate for leukaemia-associated hypercalcaemia in a 11-year-old boy.
De Schepper J; de Pont S; Smitz J; De Coster D; Schots R; Otten J
Eur J Pediatr; 1999 Sep; 158(9):765-6. PubMed ID: 10485313
[No Abstract] [Full Text] [Related]
2. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
Sims EC; Rogers PB; Besser GM; Plowman PN
Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
[TBL] [Abstract][Full Text] [Related]
3. Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
Kutluk T; Akyüz C; Yalçin B; Varan A; Büyükpamuküçu M
Med Pediatr Oncol; 1998 Jul; 31(1):39. PubMed ID: 9607431
[No Abstract] [Full Text] [Related]
4. Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate.
Cömlekçi A; Biberoglu S; Hekimsoy Z; Okan I; Pişkin O; Sekeroglu B; Alakavuklar M
Intern Med; 1998 Apr; 37(4):396-7. PubMed ID: 9630201
[TBL] [Abstract][Full Text] [Related]
5. Leukaemia-associated hypercalcaemia in a 10-year-old boy: effectiveness of aminohydroxypropylidene biphosphonate.
Boudailliez BR; Pautard BJ; Sebert JL; Kremp O; Piussan CX
Pediatr Nephrol; 1990 Sep; 4(5):510-1. PubMed ID: 2242318
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic hypocalcemia after intravenous pamidronate.
McIntyre E; Bruera E
J Palliat Care; 1996; 12(1):46-7. PubMed ID: 8857248
[TBL] [Abstract][Full Text] [Related]
7. Prolonged hypocalcaemia after pamidronate infusion in Riedel's thyroiditis associated hypoparathyroidism.
Boumans D; de Vries PA; Rikken NE; Laverman GD
Neth J Med; 2013 Oct; 71(8):442-3. PubMed ID: 24127509
[No Abstract] [Full Text] [Related]
8. Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.
McIntyre HD; Cameron DP; Urquhart SM; Davies WE
Postgrad Med J; 1989 Apr; 65(762):244-6. PubMed ID: 2594602
[TBL] [Abstract][Full Text] [Related]
9. Hypocalcemia following pamidronate administration for bone metastases of solid tumor: three clinical case reports.
Champallou C; Basuyau JP; Veyret C; Chinet P; Debled M; Chevrier A; Grongnet MH; Brunelle P
J Pain Symptom Manage; 2003 Feb; 25(2):185-90. PubMed ID: 12590034
[TBL] [Abstract][Full Text] [Related]
10. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
[TBL] [Abstract][Full Text] [Related]
11. [Pamidronate in the treatment of tumor-associated hypercalcemia].
Pecherstorfer M; Janisch S; Marosi C; Wogritsch C; Bosse C; Schratzberger W; Gerber E; Fortelny A; Lenzhofer R; Rainer H
Klin Wochenschr; 1991 Oct; 69(15):690-5. PubMed ID: 1795492
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic hypocalcaemia after treatment with high-dose aminohydroxypropylidene diphosphonate.
Jodrell DI; Iveson TJ; Smith IE
Lancet; 1987 Mar; 1(8533):622. PubMed ID: 2881152
[No Abstract] [Full Text] [Related]
13. A case of severe, irreversible hypocalcemia after one dose of pamidronate administered for hypercalcemia of malignancy.
Kim S
J Oncol Pharm Pract; 2019 Oct; 25(7):1787-1793. PubMed ID: 30419769
[TBL] [Abstract][Full Text] [Related]
14. Chronic high-dose pamidronate in refractory malignant hypercalcaemia.
Judson I; Booth F; Gore M; McElwain T
Lancet; 1990 Mar; 335(8692):802. PubMed ID: 1969552
[No Abstract] [Full Text] [Related]
15. Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment.
Gibbs CJ; Peacock M
Postgrad Med J; 1986 Oct; 62(732):937-8. PubMed ID: 3774726
[TBL] [Abstract][Full Text] [Related]
16. Single high-dose (45 mg) infusions of aminohydroxypropylidene diphosphonate for severe malignant hypercalcemia.
Mannix KA; Carmichael J; Harris AL; Cantwell BM
Cancer; 1989 Sep; 64(6):1358-61. PubMed ID: 2766228
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic hypocalcaemia following intravenous pamidronate in cancer patients.
Chong G; Hoang T; Davis ID
Aust N Z J Med; 1999 Feb; 29(1):96-7. PubMed ID: 10200826
[No Abstract] [Full Text] [Related]
18. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract][Full Text] [Related]
19. Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
Kutluk MT; Hazar V; Akyüz C; Varan A; Büyükpamukçu M
J Pediatr; 1997 May; 130(5):828-31. PubMed ID: 9152297
[TBL] [Abstract][Full Text] [Related]
20. Update on the medical treatment of hypercalcemia of malignancy.
Hall TG; Schaiff RA
Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
